<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.6.1" -->
<rss version="0.92">
<channel>
	<title>Piracetam Research</title>
	<link>http://www.piracetam.info</link>
	<description>Piracetam Research</description>
	<lastBuildDate>Tue, 17 Aug 2010 07:59:10 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Piracetam - the original nootropic</title>
		<description>Piracetam - the original nootropic
by James South MA

Piracetam (technically known as 2-oxo-pyrrolidone) was developed in the mid-1960's by UCB pharmaceutical company of Belgium. It was originally used to treat motion sickness. (1) Between 1968 and 1972, however, there was an explosion of Piracetam research which uncovered its ability to facilitate ...</description>
		<link>http://www.piracetam.info/piracetam-the-original-nootropic</link>
			</item>
	<item>
		<title>Nootropics - reviewing piracetam &#038; analogues</title>
		<description>Nootropics - reviewing piracetam and analogues
by James South M.A

Over 30 years have passed since the "Nootropic Revolution" quietly began with the development of Piracetam in the late medical efficacy with a virtual absence of toxicity and side effects; something rarely seen with more standard medical drugs.

More importantly, they offered promise ...</description>
		<link>http://www.piracetam.info/nootropics-reviewing-piracetam-analogues</link>
			</item>
	<item>
		<title>piracetam used in Parkinson&#8217;s</title>
		<description>Piracetam improves visuomotor and cognitive deficits in early Parkinsonism.
Oepen G, Eisele K, Thoden U, Birg W.
Pharmacopsychiatry 1985 Nov;18(6):343-6
Abstract
The influence of piracetam on Parkinsonism was studied in 18 patients and 18 matched controls. Clinical, visuomotor and psychometric variables were measured. Piracetam improved visuomotor reaction time (RT) and accuracy in 6 mildly ...</description>
		<link>http://www.piracetam.info/piracetam-used-in-parkinsons</link>
			</item>
	<item>
		<title>piracetam reduction of myoclonus</title>
		<description>Antimyoclonic action of piracetam.
Obeso JA, Artieda J, Luquin MR, Vaamonde J, Martinez Lage JM.
Clin Neuropharmacol 1986;9(1):58-64
Abstract
Five patients with myoclonus were treated with oral piracetam (8-9 g/day). All patients had action-sensitive and/or stimulus-sensitive myoclonus and enhanced amplitude of somatosensory evoked potentials. Piracetam produced a marked reduction of the myoclonus in the ...</description>
		<link>http://www.piracetam.info/piracetam-reduction-of-myoclonus</link>
			</item>
	<item>
		<title>piracetam and mental performance</title>
		<description>Piracetam-induced improvement of mental performance.
Mindus P, Cronholm B, Levander SE, Schalling D.
Acta Psychiatr Scand 1976 Aug;54(2):150-60
Abstract
A double-blind, intra-individual cross-over comparison of the mental performance of 18 aging, non-deteriorated individuals during two 4-week periods of piracetam and placebo administration was performed using conventional and computerized perceptual-motor tasks. In a majority of ...</description>
		<link>http://www.piracetam.info/piracetam-and-mental-performance</link>
			</item>
	<item>
		<title>piracetam effects on schizophrenia</title>
		<description>Some effects of piracetam on chronic schizophrenia.
Dimond SJ, Scammell RE, Pryce IG, Huws D, Gray C.
Psychopharmacology (Berl) 1979 Sep;64(3):341-8
Abstract
A study is described of effects of piracetam on chronic schizophrenia. Piracetam acts on the central nervous system with the cerebral cortex as their target. Chronic schizophrenic patients on the drug showed ...</description>
		<link>http://www.piracetam.info/piracetam-effects-on-schizophrenia</link>
			</item>
	<item>
		<title>piracetam protects in brain edema</title>
		<description>Efficacy of cerebroprotective substances in the management of functional disorders induced by the cytotoxic brain oedema-producing substance hexachlorophene.
Andreas K.

Institute of Pharmacology and Toxicology,
Medical Academy Carl Gustav Carus Dresden,
Federal Republic of Germany.
Naunyn Schmiedebergs Arch Pharmacol 1993 Jan;347(1):79-83
Abstract
The hexachlorophene-induced cytotoxic brain oedema is used as experimental model of brain damage, suitable for ...</description>
		<link>http://www.piracetam.info/piracetam-protects-in-brain-edema</link>
			</item>
	<item>
		<title>piracetam treatment of migraine</title>
		<description>Vestibular disorders in patients with migraine.
Szirmai A.

Department of Oto-Rhino-Laryngology,
Head and Neck Surgery,
Semmelweis University Medical School,
Budapest, Hungary.
Eur Arch Otorhinolaryngol 1997;254 Suppl 1:S55-7
Abstract
Vestibular symptoms frequently occur in patients with migraine headache. The common migraine is defined in neurology as a unilateral, pulsating headache, which may be associated with nausea and vomiting, and ...</description>
		<link>http://www.piracetam.info/piracetam-treatment-of-migraine</link>
			</item>
	<item>
		<title>piracetam improves memory</title>
		<description>Increase in the power of human memory in normal man through the use of drugs.
Dimond SJ, Brouwers EM.
Psychopharmacology (Berl) 1976 Sep 29;49(3):307-9
Abstract
Piracetam, a drug reported to facilitate learning in animals was tested for its effect on man by administering it to normal volunteers. The subjects were given 3x4 capsules at ...</description>
		<link>http://www.piracetam.info/piracetam-improves-memory</link>
			</item>
	<item>
		<title>piracetam in cerebral palsy</title>
		<description>Piracetam in the management of spasticity in cerebral palsy.
Maritz NG, Muller FO, Pompe van Meerdervoort HF.
S Afr Med J 1978 Jun 3;53(22):889-91
Abstract
This article is a preliminary report of a new indication for the drug piracetam. It was found that piracetam was useful for the control of spasticity in 8 out ...</description>
		<link>http://www.piracetam.info/piracetam-in-cerebral-palsy</link>
			</item>
</channel>
</rss>
